Anti-Infectives

TMC's McGuire preps CRE antibiotic for market

TMC's McGuire preps CRE antibiotic for market

By

The Medicines Company's commercial lead for infection disease care talks about its breakthrough antidote for carbapenem-resistant enterobacteriaceae.

OPINION

Email Newsletters